期刊文献+

516株金黄色葡萄球菌对9种抗生素的耐药性分析 被引量:23

Resistance of 516 Staphylococcus aureus Isolates of to 9 Kinds of Antibiotics
下载PDF
导出
摘要 目的了解金黄色葡萄球菌对9种常见抗生素的耐药性,为临床治疗提供依据. 方法按NCCLS纸片扩散方法,测定并判读金黄色葡萄球菌对抗生素的耐药性,并以NCCLS纸片法测定MRSA耐药表型. 结果 516株金黄色葡萄球菌对青霉素的耐药率均约90%,除对万古霉素和复方新诺明外,2004年该菌对监测的9种抗生素的7种药物的耐药率>57.8%,MRSA菌为64.4%,目前我院未检测到对万古霉素耐药的金黄色葡萄球菌;516株金黄色葡萄球菌MRSA的平均检出率为44.8%;MSSA对青霉素的耐药率高达86.6%,对红霉素耐药率为55.1%,对克林霉素、四环素和复方新诺明的耐药率约20%~30%;MRSA除复方新诺明和万古霉素外,对其他各类药物耐药性明显升高,对环丙沙星耐药增高最明显(77.5%). 结论金黄色葡萄球菌感染发生率及耐药性快速增长, MRSA对各类抗生素多重耐药. OBJECTIVE To investigate the resistance of Staphylococcus aureus isolated from 2000 to 2004 to nine kinds of antimicrobial agents. METHODS Susceptibility test was performed by disk diffusion method and analyzed by software WHONET 5.3. RESULTS The 516 S. aureus strains showed resistant rates of 90% to penicillin, the percentage of resistance of S. aureus to the nine drugs increased with years, accounted for over 57.8% except for sulfamethoxazole/trimethoprim and vancomycin in 2004. The isolated rate of MRSA was 44.8%. The resistance of MSSA to penicillin and erythromycin was 86.6% and 55. 1%, respectively. None of the isolates showed resistance to vancomycin. CONCLUSIONS There is an increasing trend of isolated rate and resistance in S. aureus. MRSA strains are multidrug resistant.
机构地区 解放军总医院
出处 《中华医院感染学杂志》 CAS CSCD 北大核心 2005年第9期1054-1055,共2页 Chinese Journal of Nosocomiology
关键词 金黄色葡萄球菌 耐药性 Staphylococcus aureus Resistance
  • 相关文献

参考文献4

二级参考文献19

  • 1马纪平,苏建荣,靳景图.耐甲氧苯青霉素葡萄球菌[J].中华医学检验杂志,1996,19(3):186-188. 被引量:82
  • 2GatesRH著 汪明明 崔速南译.美国最新I临床医学问答-感染性疾病[M].北京:海洋出版社,2000.79.
  • 3Fiebelkorn KR, Crawford SA, McElmeel ML, et al. Practical disk diffusion method for detection of inducible clindamycin resistance in Staphylococcus aureus and coagulase-negative staphylococci. J Clin Microbiol, 2003, 41: 4740-4744.
  • 4Lina G, Quaglia A, Reverdy ME, et al. Distribution of genes encoding resistance to macrolides, lincosamides, and streptogramins among staphylococci. Antimicrob Agents Chemother,1999, 43:1062-1066.
  • 5Khan SA, Nawaz MS, Khan AA, et al. Simultaneous detection of erythromycin-resistant methylase genes erm A and ermC from Staphylococcus spp by multiplex-PCR. Mol Cell Probes, 1999, 13:381-387.
  • 6Schreckenberger PC, Ilendo E,Ristow KL. Incidence of constitutive and inducible clindamycin resistance in staphylococcus aureus and coagulase-Negative Staphylococci in a community and a tertiary care hospital. J Clin Microbiol, 2004, 42: 2777-2779.
  • 7Shimada K, Matsumoto T, Komiya I, et al. Phase I clinical studies on a novel oral cephem antibiotic, ME1207. Chemother, 1992 ,40(Suppl 2):105-119.
  • 8Nishino T, Takata T, Otsuki M, et al. In vitro and in vivo antibacterial activity of ME1207, a new oral cephem antibiotic. Chemother, 1992, 40(Suppl 2): 37-50.
  • 9Pressed review with community acquired infection. Jpn J Antibiot,(Suppl B) 2001, 52.
  • 10Li JT, Hou F, Lu H, et al. Phase I clinical trial of Cefditoren pivoxil (ME-1207): Pharmacokinetics in healthy volunteers. Drugs Exptl Clin Res, 1997, ⅩⅩⅩⅢ(5/6): 145-150.

共引文献177

同被引文献165

引证文献23

二级引证文献204

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部